Clinical characteristics and analysis of prognostic factors in methicillin-resistant Staphylococcus aureus

Kotaro Mitsutake1, Natsuki Shinya1, Masafumi Seki2

  • 1Department of Infectious Diseases and Infection Control, Saitama International Medical Center, Saitama Medical University, 397-1, Hidaka, Saitama, 350-1298, Japan.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus infective endocarditis (MRSA-IE) has high mortality. Surgical treatment significantly improves prognosis for MRSA-IE patients, reducing mortality rates.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) is a severe condition with high mortality rates.
  • Understanding patient characteristics and prognostic factors in Japan is crucial for improving outcomes.

Purpose of the Study:

  • To investigate the clinical features of patients diagnosed with MRSA-IE in Japan.
  • To identify key factors influencing the prognosis of MRSA-IE.

Main Methods:

  • A retrospective analysis of 65 patients diagnosed with MRSA-IE between January 2015 and April 2019.
  • Data collected from 19 medical centers across Japan.

Main Results:

  • The study included patients with a mean age of 67 years; 26% were female. Common factors included nosocomial infections (50%), prosthetic valve involvement (25%), hemodialysis (20%), and diabetes (20%). Congestive heart failure was prevalent in 86% of patients.
  • In-hospital mortality was 46%, with multi-organ failure as the leading cause of death (43%). Prognostic factors for mortality included advanced age, disseminated intravascular coagulation, and initial antibiotic therapy with daptomycin and/or linezolid.
  • Surgical treatment was associated with significantly lower 30-day mortality (OR, 0.026; P=.008) and in-hospital mortality (OR, 0.130; P=.008).

Conclusions:

  • Mortality associated with MRSA-IE remains a significant clinical challenge.
  • Surgical intervention emerges as a critical factor for improving survival in patients with MRSA-IE.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...